Phase A Phase 2 Study Evaluating Response and Biomarkers in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer Treated With Nivolumab in Combination With Relatlimab
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Nivolumab (Primary) ; Relatlimab (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 03 Jan 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Dec 2018 to 1 Jan 2019.
- 07 Dec 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Nov 2018 to 1 Dec 2018.
- 13 Nov 2018 Status changed from not yet recruiting to recruiting.